Fischer Medical Ventures Ltd

Fischer Medical Ventures Limited, formerly Fischer Chemic Limited, announced the appointment of David Yeow as an additional independent director with effect from September 3, 2026, for a term of five years, subject to shareholder approval. The company also reconstituted its audit committee following Yeow’s appointment, and will hold its 33rd Annual General Meeting on September 29, 2026, via video conferencing, while the company’s share transfer books will be closed from September 23, 2026, to September 29, 2026.

Fischer Medical Ventures Limited, formerly Fischer Chemic Limited, informed the BSE Limited and National Stock Exchange of India Ltd. that the register of members and share transfer books will remain closed from September 23, 2026, to September 29, 2026, for the Annual General Meeting scheduled on September 29, 2026, with a record date of September 22, 2026, to determine dividend and voting rights, and a cut-off date of September 4, 2026, for dispatch of the Annual General Meeting notice.

Fischer Medical Ventures Limited announced that its Board of Directors approved the allotment of 4,54,210 equity shares with a face value of Re. 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40, to FMV Holdings Pte Ltd, a promoter entity, upon the exercise of warrants. The company received Rs 79,71,385.50 in consideration for the allotment.

Fischer Medical Ventures Limited announced that its board approved the allotment of 2,05,05,909 equity shares with a face value of Re. 1 each at an issue price of Rs. 23.40 per share, including a premium of Rs. 22.40 per share, following the conversion of warrants, receiving Rs. 35,98,78,702.95 in consideration. The allottees include Mr. Shankar Varadharajan, FMV Holdings Pte Ltd, and Vritti Hitesh Kawa, with Mr. Shankar Varadharajan converting 60,00,000 warrants, FMV Holdings Pte Ltd converting 73,35,909 warrants, and Vritti Hitesh Kawa converting 71,70,000 warrants.

Fischer Medical Ventures Limited announced that its board approved the allotment of 1,42,78,217 equity shares with a face value of Re. 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40, following the conversion of warrants. The company received Rs 25,05,82,708.35 in consideration for the allotment, with Mr. Shankar Varadharajan, FMV Holdings Pte Ltd, and Vikasa India Eif I Fund being the allottees.

Fischer Medical Ventures Limited informed the BSE Limited and National Stock Exchange of India Ltd. that its board approved the allotment of 66,31,664 equity shares with a face value of Re. 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40, upon the exercise of convertible warrants by promoters and a promoter group entity, FMV Holdings Pte Ltd, receiving Rs 11,63,85,703 in consideration.

Fischer Medical Ventures Limited announced that its Board of Directors approved the allotment of 23,00,000 equity shares with a face value of Re. 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40, to Mr. Shankar Varadharajan, a promoter, upon the exercise of convertible warrants, resulting in a total consideration received of Rs 4,03,65,000.

Fischer Medical Ventures Limited will hold a board meeting on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Ltd. The trading window for the company's equity shares is currently closed for designated persons and will remain so until 48 hours after the financial results are declared.

Fischer Medical Ventures Limited announced that its wholly owned subsidiary, Time Medical International Ventures (India) Private Limited, has partnered with Parul Sevashram Hospital in Vadodara to install its DRIS–iMRI Medharanya Suite, a portable intraoperative MRI system, for approximately Rs 0.

Fischer Medical Ventures Limited announced that its associate company, Nanomedic Technologies Ltd. of Lod, Israel, has received regulatory clearance from India's Central Licensing Authority (CDSCO) to import and distribute the Spincare Portable Wound Care System, marking the first regulatory clearance in India for a portable electrospun wound care system. The approval grants Fischer Medical Ventures exclusive rights to distribute the Spincare system across India and Southeast Asia, positioning the company to capture a share of the combined multi-billion dollar wound care market, currently valued at approximately USD 380 million in India and USD 354 million in Southeast Asia by 2030.